Global Pharmaceutical Excipient Albumin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 112
Published Date: 11 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Pharmaceutical Excipient Albumin market size was valued at USD 735.7 million in 2023 and is forecast to a readjusted size of USD 1233 million by 2030 with a CAGR of 7.7% during review period.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Pharmaceutical Excipient Albumin industry chain, the market status of Cell Culture Media (Human Serum Albumin, Recombinant Albumin), Medical Supplements (Human Serum Albumin, Recombinant Albumin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pharmaceutical Excipient Albumin.
Regionally, the report analyzes the Pharmaceutical Excipient Albumin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pharmaceutical Excipient Albumin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pharmaceutical Excipient Albumin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pharmaceutical Excipient Albumin industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Human Serum Albumin, Recombinant Albumin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pharmaceutical Excipient Albumin market.
Regional Analysis: The report involves examining the Pharmaceutical Excipient Albumin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pharmaceutical Excipient Albumin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pharmaceutical Excipient Albumin:
Company Analysis: Report covers individual Pharmaceutical Excipient Albumin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pharmaceutical Excipient Albumin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cell Culture Media, Medical Supplements).
Technology Analysis: Report covers specific technologies relevant to Pharmaceutical Excipient Albumin. It assesses the current state, advancements, and potential future developments in Pharmaceutical Excipient Albumin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pharmaceutical Excipient Albumin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pharmaceutical Excipient Albumin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Human Serum Albumin
Recombinant Albumin
Market segment by Application
Cell Culture Media
Medical Supplements
Major players covered
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Excipient Albumin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Excipient Albumin, with price, sales, revenue and global market share of Pharmaceutical Excipient Albumin from 2019 to 2024.
Chapter 3, the Pharmaceutical Excipient Albumin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Excipient Albumin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Pharmaceutical Excipient Albumin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Excipient Albumin.
Chapter 14 and 15, to describe Pharmaceutical Excipient Albumin sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical Excipient Albumin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pharmaceutical Excipient Albumin Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Human Serum Albumin
1.3.3 Recombinant Albumin
1.4 Market Analysis by Application
1.4.1 Overview: Global Pharmaceutical Excipient Albumin Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cell Culture Media
1.4.3 Medical Supplements
1.5 Global Pharmaceutical Excipient Albumin Market Size & Forecast
1.5.1 Global Pharmaceutical Excipient Albumin Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Pharmaceutical Excipient Albumin Sales Quantity (2019-2030)
1.5.3 Global Pharmaceutical Excipient Albumin Average Price (2019-2030)
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL Pharmaceutical Excipient Albumin Product and Services
2.1.4 CSL Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 CSL Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Pharmaceutical Excipient Albumin Product and Services
2.2.4 Grifols Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Grifols Recent Developments/Updates
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda Pharmaceutical Excipient Albumin Product and Services
2.3.4 Takeda Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Takeda Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Pharmaceutical Excipient Albumin Product and Services
2.4.4 Octapharma Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Octapharma Recent Developments/Updates
2.5 Hualan Bio
2.5.1 Hualan Bio Details
2.5.2 Hualan Bio Major Business
2.5.3 Hualan Bio Pharmaceutical Excipient Albumin Product and Services
2.5.4 Hualan Bio Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Hualan Bio Recent Developments/Updates
2.6 CBPO
2.6.1 CBPO Details
2.6.2 CBPO Major Business
2.6.3 CBPO Pharmaceutical Excipient Albumin Product and Services
2.6.4 CBPO Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 CBPO Recent Developments/Updates
2.7 Shanghai RAAS
2.7.1 Shanghai RAAS Details
2.7.2 Shanghai RAAS Major Business
2.7.3 Shanghai RAAS Pharmaceutical Excipient Albumin Product and Services
2.7.4 Shanghai RAAS Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Shanghai RAAS Recent Developments/Updates
2.8 Kedrion
2.8.1 Kedrion Details
2.8.2 Kedrion Major Business
2.8.3 Kedrion Pharmaceutical Excipient Albumin Product and Services
2.8.4 Kedrion Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Kedrion Recent Developments/Updates
2.9 LFB Group
2.9.1 LFB Group Details
2.9.2 LFB Group Major Business
2.9.3 LFB Group Pharmaceutical Excipient Albumin Product and Services
2.9.4 LFB Group Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 LFB Group Recent Developments/Updates
2.10 Albumedix
2.10.1 Albumedix Details
2.10.2 Albumedix Major Business
2.10.3 Albumedix Pharmaceutical Excipient Albumin Product and Services
2.10.4 Albumedix Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Albumedix Recent Developments/Updates
2.11 Biotest
2.11.1 Biotest Details
2.11.2 Biotest Major Business
2.11.3 Biotest Pharmaceutical Excipient Albumin Product and Services
2.11.4 Biotest Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Biotest Recent Developments/Updates
2.12 Merck
2.12.1 Merck Details
2.12.2 Merck Major Business
2.12.3 Merck Pharmaceutical Excipient Albumin Product and Services
2.12.4 Merck Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Merck Recent Developments/Updates
2.13 Ventria (InVitria)
2.13.1 Ventria (InVitria) Details
2.13.2 Ventria (InVitria) Major Business
2.13.3 Ventria (InVitria) Pharmaceutical Excipient Albumin Product and Services
2.13.4 Ventria (InVitria) Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Ventria (InVitria) Recent Developments/Updates
2.14 HiMedia
2.14.1 HiMedia Details
2.14.2 HiMedia Major Business
2.14.3 HiMedia Pharmaceutical Excipient Albumin Product and Services
2.14.4 HiMedia Pharmaceutical Excipient Albumin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 HiMedia Recent Developments/Updates
3.1 Global Pharmaceutical Excipient Albumin Sales Quantity by Manufacturer (2019-2024)
3.2 Global Pharmaceutical Excipient Albumin Revenue by Manufacturer (2019-2024)
3.3 Global Pharmaceutical Excipient Albumin Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Pharmaceutical Excipient Albumin by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Pharmaceutical Excipient Albumin Manufacturer Market Share in 2023
3.4.2 Top 6 Pharmaceutical Excipient Albumin Manufacturer Market Share in 2023
3.5 Pharmaceutical Excipient Albumin Market: Overall Company Footprint Analysis
3.5.1 Pharmaceutical Excipient Albumin Market: Region Footprint
3.5.2 Pharmaceutical Excipient Albumin Market: Company Product Type Footprint
3.5.3 Pharmaceutical Excipient Albumin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Pharmaceutical Excipient Albumin Market Size by Region
4.1.1 Global Pharmaceutical Excipient Albumin Sales Quantity by Region (2019-2030)
4.1.2 Global Pharmaceutical Excipient Albumin Consumption Value by Region (2019-2030)
4.1.3 Global Pharmaceutical Excipient Albumin Average Price by Region (2019-2030)
4.2 North America Pharmaceutical Excipient Albumin Consumption Value (2019-2030)
4.3 Europe Pharmaceutical Excipient Albumin Consumption Value (2019-2030)
4.4 Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value (2019-2030)
4.5 South America Pharmaceutical Excipient Albumin Consumption Value (2019-2030)
4.6 Middle East and Africa Pharmaceutical Excipient Albumin Consumption Value (2019-2030)
5.1 Global Pharmaceutical Excipient Albumin Sales Quantity by Type (2019-2030)
5.2 Global Pharmaceutical Excipient Albumin Consumption Value by Type (2019-2030)
5.3 Global Pharmaceutical Excipient Albumin Average Price by Type (2019-2030)
6.1 Global Pharmaceutical Excipient Albumin Sales Quantity by Application (2019-2030)
6.2 Global Pharmaceutical Excipient Albumin Consumption Value by Application (2019-2030)
6.3 Global Pharmaceutical Excipient Albumin Average Price by Application (2019-2030)
7.1 North America Pharmaceutical Excipient Albumin Sales Quantity by Type (2019-2030)
7.2 North America Pharmaceutical Excipient Albumin Sales Quantity by Application (2019-2030)
7.3 North America Pharmaceutical Excipient Albumin Market Size by Country
7.3.1 North America Pharmaceutical Excipient Albumin Sales Quantity by Country (2019-2030)
7.3.2 North America Pharmaceutical Excipient Albumin Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Pharmaceutical Excipient Albumin Sales Quantity by Type (2019-2030)
8.2 Europe Pharmaceutical Excipient Albumin Sales Quantity by Application (2019-2030)
8.3 Europe Pharmaceutical Excipient Albumin Market Size by Country
8.3.1 Europe Pharmaceutical Excipient Albumin Sales Quantity by Country (2019-2030)
8.3.2 Europe Pharmaceutical Excipient Albumin Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Pharmaceutical Excipient Albumin Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Pharmaceutical Excipient Albumin Sales Quantity by Type (2019-2030)
10.2 South America Pharmaceutical Excipient Albumin Sales Quantity by Application (2019-2030)
10.3 South America Pharmaceutical Excipient Albumin Market Size by Country
10.3.1 South America Pharmaceutical Excipient Albumin Sales Quantity by Country (2019-2030)
10.3.2 South America Pharmaceutical Excipient Albumin Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Pharmaceutical Excipient Albumin Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Pharmaceutical Excipient Albumin Market Drivers
12.2 Pharmaceutical Excipient Albumin Market Restraints
12.3 Pharmaceutical Excipient Albumin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Pharmaceutical Excipient Albumin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pharmaceutical Excipient Albumin
13.3 Pharmaceutical Excipient Albumin Production Process
13.4 Pharmaceutical Excipient Albumin Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pharmaceutical Excipient Albumin Typical Distributors
14.3 Pharmaceutical Excipient Albumin Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Pharmaceutical Excipient Albumin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pharmaceutical Excipient Albumin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. CSL Basic Information, Manufacturing Base and Competitors
Table 4. CSL Major Business
Table 5. CSL Pharmaceutical Excipient Albumin Product and Services
Table 6. CSL Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. CSL Recent Developments/Updates
Table 8. Grifols Basic Information, Manufacturing Base and Competitors
Table 9. Grifols Major Business
Table 10. Grifols Pharmaceutical Excipient Albumin Product and Services
Table 11. Grifols Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Grifols Recent Developments/Updates
Table 13. Takeda Basic Information, Manufacturing Base and Competitors
Table 14. Takeda Major Business
Table 15. Takeda Pharmaceutical Excipient Albumin Product and Services
Table 16. Takeda Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Takeda Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Pharmaceutical Excipient Albumin Product and Services
Table 21. Octapharma Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Octapharma Recent Developments/Updates
Table 23. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 24. Hualan Bio Major Business
Table 25. Hualan Bio Pharmaceutical Excipient Albumin Product and Services
Table 26. Hualan Bio Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Hualan Bio Recent Developments/Updates
Table 28. CBPO Basic Information, Manufacturing Base and Competitors
Table 29. CBPO Major Business
Table 30. CBPO Pharmaceutical Excipient Albumin Product and Services
Table 31. CBPO Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. CBPO Recent Developments/Updates
Table 33. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai RAAS Major Business
Table 35. Shanghai RAAS Pharmaceutical Excipient Albumin Product and Services
Table 36. Shanghai RAAS Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Shanghai RAAS Recent Developments/Updates
Table 38. Kedrion Basic Information, Manufacturing Base and Competitors
Table 39. Kedrion Major Business
Table 40. Kedrion Pharmaceutical Excipient Albumin Product and Services
Table 41. Kedrion Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Kedrion Recent Developments/Updates
Table 43. LFB Group Basic Information, Manufacturing Base and Competitors
Table 44. LFB Group Major Business
Table 45. LFB Group Pharmaceutical Excipient Albumin Product and Services
Table 46. LFB Group Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. LFB Group Recent Developments/Updates
Table 48. Albumedix Basic Information, Manufacturing Base and Competitors
Table 49. Albumedix Major Business
Table 50. Albumedix Pharmaceutical Excipient Albumin Product and Services
Table 51. Albumedix Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Albumedix Recent Developments/Updates
Table 53. Biotest Basic Information, Manufacturing Base and Competitors
Table 54. Biotest Major Business
Table 55. Biotest Pharmaceutical Excipient Albumin Product and Services
Table 56. Biotest Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Biotest Recent Developments/Updates
Table 58. Merck Basic Information, Manufacturing Base and Competitors
Table 59. Merck Major Business
Table 60. Merck Pharmaceutical Excipient Albumin Product and Services
Table 61. Merck Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Merck Recent Developments/Updates
Table 63. Ventria (InVitria) Basic Information, Manufacturing Base and Competitors
Table 64. Ventria (InVitria) Major Business
Table 65. Ventria (InVitria) Pharmaceutical Excipient Albumin Product and Services
Table 66. Ventria (InVitria) Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Ventria (InVitria) Recent Developments/Updates
Table 68. HiMedia Basic Information, Manufacturing Base and Competitors
Table 69. HiMedia Major Business
Table 70. HiMedia Pharmaceutical Excipient Albumin Product and Services
Table 71. HiMedia Pharmaceutical Excipient Albumin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. HiMedia Recent Developments/Updates
Table 73. Global Pharmaceutical Excipient Albumin Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 74. Global Pharmaceutical Excipient Albumin Revenue by Manufacturer (2019-2024) & (USD Million)
Table 75. Global Pharmaceutical Excipient Albumin Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 76. Market Position of Manufacturers in Pharmaceutical Excipient Albumin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 77. Head Office and Pharmaceutical Excipient Albumin Production Site of Key Manufacturer
Table 78. Pharmaceutical Excipient Albumin Market: Company Product Type Footprint
Table 79. Pharmaceutical Excipient Albumin Market: Company Product Application Footprint
Table 80. Pharmaceutical Excipient Albumin New Market Entrants and Barriers to Market Entry
Table 81. Pharmaceutical Excipient Albumin Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Pharmaceutical Excipient Albumin Sales Quantity by Region (2019-2024) & (K Units)
Table 83. Global Pharmaceutical Excipient Albumin Sales Quantity by Region (2025-2030) & (K Units)
Table 84. Global Pharmaceutical Excipient Albumin Consumption Value by Region (2019-2024) & (USD Million)
Table 85. Global Pharmaceutical Excipient Albumin Consumption Value by Region (2025-2030) & (USD Million)
Table 86. Global Pharmaceutical Excipient Albumin Average Price by Region (2019-2024) & (US$/Unit)
Table 87. Global Pharmaceutical Excipient Albumin Average Price by Region (2025-2030) & (US$/Unit)
Table 88. Global Pharmaceutical Excipient Albumin Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Global Pharmaceutical Excipient Albumin Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Global Pharmaceutical Excipient Albumin Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Global Pharmaceutical Excipient Albumin Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Global Pharmaceutical Excipient Albumin Average Price by Type (2019-2024) & (US$/Unit)
Table 93. Global Pharmaceutical Excipient Albumin Average Price by Type (2025-2030) & (US$/Unit)
Table 94. Global Pharmaceutical Excipient Albumin Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Global Pharmaceutical Excipient Albumin Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Global Pharmaceutical Excipient Albumin Consumption Value by Application (2019-2024) & (USD Million)
Table 97. Global Pharmaceutical Excipient Albumin Consumption Value by Application (2025-2030) & (USD Million)
Table 98. Global Pharmaceutical Excipient Albumin Average Price by Application (2019-2024) & (US$/Unit)
Table 99. Global Pharmaceutical Excipient Albumin Average Price by Application (2025-2030) & (US$/Unit)
Table 100. North America Pharmaceutical Excipient Albumin Sales Quantity by Type (2019-2024) & (K Units)
Table 101. North America Pharmaceutical Excipient Albumin Sales Quantity by Type (2025-2030) & (K Units)
Table 102. North America Pharmaceutical Excipient Albumin Sales Quantity by Application (2019-2024) & (K Units)
Table 103. North America Pharmaceutical Excipient Albumin Sales Quantity by Application (2025-2030) & (K Units)
Table 104. North America Pharmaceutical Excipient Albumin Sales Quantity by Country (2019-2024) & (K Units)
Table 105. North America Pharmaceutical Excipient Albumin Sales Quantity by Country (2025-2030) & (K Units)
Table 106. North America Pharmaceutical Excipient Albumin Consumption Value by Country (2019-2024) & (USD Million)
Table 107. North America Pharmaceutical Excipient Albumin Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Europe Pharmaceutical Excipient Albumin Sales Quantity by Type (2019-2024) & (K Units)
Table 109. Europe Pharmaceutical Excipient Albumin Sales Quantity by Type (2025-2030) & (K Units)
Table 110. Europe Pharmaceutical Excipient Albumin Sales Quantity by Application (2019-2024) & (K Units)
Table 111. Europe Pharmaceutical Excipient Albumin Sales Quantity by Application (2025-2030) & (K Units)
Table 112. Europe Pharmaceutical Excipient Albumin Sales Quantity by Country (2019-2024) & (K Units)
Table 113. Europe Pharmaceutical Excipient Albumin Sales Quantity by Country (2025-2030) & (K Units)
Table 114. Europe Pharmaceutical Excipient Albumin Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Europe Pharmaceutical Excipient Albumin Consumption Value by Country (2025-2030) & (USD Million)
Table 116. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Type (2019-2024) & (K Units)
Table 117. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Type (2025-2030) & (K Units)
Table 118. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Application (2019-2024) & (K Units)
Table 119. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Application (2025-2030) & (K Units)
Table 120. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Region (2019-2024) & (K Units)
Table 121. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity by Region (2025-2030) & (K Units)
Table 122. Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value by Region (2019-2024) & (USD Million)
Table 123. Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value by Region (2025-2030) & (USD Million)
Table 124. South America Pharmaceutical Excipient Albumin Sales Quantity by Type (2019-2024) & (K Units)
Table 125. South America Pharmaceutical Excipient Albumin Sales Quantity by Type (2025-2030) & (K Units)
Table 126. South America Pharmaceutical Excipient Albumin Sales Quantity by Application (2019-2024) & (K Units)
Table 127. South America Pharmaceutical Excipient Albumin Sales Quantity by Application (2025-2030) & (K Units)
Table 128. South America Pharmaceutical Excipient Albumin Sales Quantity by Country (2019-2024) & (K Units)
Table 129. South America Pharmaceutical Excipient Albumin Sales Quantity by Country (2025-2030) & (K Units)
Table 130. South America Pharmaceutical Excipient Albumin Consumption Value by Country (2019-2024) & (USD Million)
Table 131. South America Pharmaceutical Excipient Albumin Consumption Value by Country (2025-2030) & (USD Million)
Table 132. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Type (2019-2024) & (K Units)
Table 133. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Type (2025-2030) & (K Units)
Table 134. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Application (2019-2024) & (K Units)
Table 135. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Application (2025-2030) & (K Units)
Table 136. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Region (2019-2024) & (K Units)
Table 137. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity by Region (2025-2030) & (K Units)
Table 138. Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value by Region (2019-2024) & (USD Million)
Table 139. Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value by Region (2025-2030) & (USD Million)
Table 140. Pharmaceutical Excipient Albumin Raw Material
Table 141. Key Manufacturers of Pharmaceutical Excipient Albumin Raw Materials
Table 142. Pharmaceutical Excipient Albumin Typical Distributors
Table 143. Pharmaceutical Excipient Albumin Typical Customers
List of Figures
Figure 1. Pharmaceutical Excipient Albumin Picture
Figure 2. Global Pharmaceutical Excipient Albumin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pharmaceutical Excipient Albumin Consumption Value Market Share by Type in 2023
Figure 4. Human Serum Albumin Examples
Figure 5. Recombinant Albumin Examples
Figure 6. Global Pharmaceutical Excipient Albumin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Pharmaceutical Excipient Albumin Consumption Value Market Share by Application in 2023
Figure 8. Cell Culture Media Examples
Figure 9. Medical Supplements Examples
Figure 10. Global Pharmaceutical Excipient Albumin Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Pharmaceutical Excipient Albumin Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Pharmaceutical Excipient Albumin Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Pharmaceutical Excipient Albumin Average Price (2019-2030) & (US$/Unit)
Figure 14. Global Pharmaceutical Excipient Albumin Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Pharmaceutical Excipient Albumin Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Pharmaceutical Excipient Albumin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Pharmaceutical Excipient Albumin Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Pharmaceutical Excipient Albumin Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Pharmaceutical Excipient Albumin Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Pharmaceutical Excipient Albumin Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Pharmaceutical Excipient Albumin Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Pharmaceutical Excipient Albumin Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Pharmaceutical Excipient Albumin Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Pharmaceutical Excipient Albumin Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Pharmaceutical Excipient Albumin Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Pharmaceutical Excipient Albumin Average Price by Type (2019-2030) & (US$/Unit)
Figure 29. Global Pharmaceutical Excipient Albumin Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Pharmaceutical Excipient Albumin Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Pharmaceutical Excipient Albumin Average Price by Application (2019-2030) & (US$/Unit)
Figure 32. North America Pharmaceutical Excipient Albumin Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Pharmaceutical Excipient Albumin Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Pharmaceutical Excipient Albumin Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Pharmaceutical Excipient Albumin Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Pharmaceutical Excipient Albumin Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Pharmaceutical Excipient Albumin Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Pharmaceutical Excipient Albumin Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Pharmaceutical Excipient Albumin Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Pharmaceutical Excipient Albumin Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Pharmaceutical Excipient Albumin Consumption Value Market Share by Region (2019-2030)
Figure 52. China Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Pharmaceutical Excipient Albumin Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Pharmaceutical Excipient Albumin Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Pharmaceutical Excipient Albumin Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Pharmaceutical Excipient Albumin Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Pharmaceutical Excipient Albumin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Pharmaceutical Excipient Albumin Market Drivers
Figure 73. Pharmaceutical Excipient Albumin Market Restraints
Figure 74. Pharmaceutical Excipient Albumin Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Pharmaceutical Excipient Albumin in 2023
Figure 77. Manufacturing Process Analysis of Pharmaceutical Excipient Albumin
Figure 78. Pharmaceutical Excipient Albumin Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
CSL Grifols Takeda Octapharma Hualan Bio CBPO Shanghai RAAS Kedrion LFB Group Albumedix Biotest Merck Ventria (InVitria) HiMedia
Related Reports
31 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
